Low levels are associated with aging, increased risk of infections (including COVID-19), cancer, neurological problems, diabetes, and more
doi:10.1111/ejn.14096 2022 The Author(s)
1 Department of Paediatrics, University of Cambridge, Cambridge, UK, 2 NIHR Cambridge Biomedical Research Centre, Core Biochemistry Assay Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, 3 Institute of Metabolic Science and Department of Medicine, University of Cambridge, Cambridge, UK, 4 Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium
This stepwise approach aims to improve gastrointestinal tolerability, though it does not eliminate all adverse effects
We use your biology as a roadmap